Researchers believe GLP-1 medications may influence nicotine dependence because the systems that regulate appetite and addiction share overlapping reward pathways, including dopamine signaling, impulse control and reward reinforcement
You may experience symptoms such as loss of appetite, nausea, bloating, weight loss, and frequent burping on top of the burning pain in your abdomen
PMI Research and FDA Review Philip Morris International, the manufacturer of IQOS, has conducted extensive internal research on harmful compound levels in IQOS aerosol compared to cigarette smoke
It comes free after about a quarter of a turn, so turn it slowly to avoid pulling the wires
Emerging trends and innovations promise to revolutionize how the tobacco industry approaches sustainability and recyclability in packaging
Voltage Energy used (Watts)